News
-
-
-
COMMUNIQUÉ DE PRESSE
Press Release: EADV: Sanofi’s brivekimig achieved positive results in hidradenitis suppurativa in phase 2a study
Sanofi's brivekimig shows positive results in phase 2a study for hidradenitis suppurativa, presenting clinically meaningful improvements in primary and secondary endpoints in biologic-naïve patients -
COMMUNIQUÉ DE PRESSE
Sanofi: Disclosure of trading in own shares
-
-
-
-
-
-